AI for Drug Discovery Open Innovation Forum

Overview: Safe and responsible AI needs to be developed in the open. The objective of this forum is to establish a world-class open research community to drive the development, evaluation, and large-scale adoption of AI foundation models for accelerated scientific advancements for drug discovery. The one-day event will consist of an opening session with keynotes and panels highlighting the state of the art in AI technologies and pressing bottlenecks and challenges in drug discovery, followed by breakout sessions to identify and prioritize key AI technologies and activities that should be developed in the open. The event will also include, and hands-on sessions with opportunities to work with open-source foundation models for drug discovery such as Biomedical Foundation Models. The forum will serve as the kickoff event of a new AI for Drug Discovery working group within the AI Alliance. A key objective of the forum is to identify open development priorities for this working group.

Keynote Speakers:

Jeremy Jenkins, US Head of Discovery Sciences, Novartis Biomedical Research

Joseph Loscalzo, Samuel A. Levine Professor of Medicine and the Hersey Distinguished Professor of the Theory and Practice of Medicine at Harvard Medical School, and Physician-in-Chief Emeritus at Brigham and Women’s Hospital.

Sean Mooney, National Institutes of Health (NIH) Director of the Center for Information Technology, and Associate Director, IT

Mona Singh, Wang Family Professor, Computer Science, Princeton University

Organizers: This event is organized & cosponsored by Boston University’s Hariri Institute, BU Bioengineering Technology & Entrepreneurship Center, Red Hat, IBM, and the Cleveland Clinic and The AI Alliance.

This event is open to everyone—we encourage anyone interested to join us and participate.